DPP-4 inhibitors for Type 2 Diabetes. Who, when, and why?

AUS

$0

free

ADEA, RACGP CPD Program

1 hr

Endocrinology, Medication Management

2 Credits

This course is expired! Browse All Courses
LEARN MORE

Course Description

Medical treatment of Type 2 Diabetes (T2D) has become increasingly complex, as new classes of hypoglycaemic medications are developed and clinical guidelines are updated to reflect these developments.

DPP4is are a useful addition to many T2D treatment plans, especially for complex patients with comorbidities that limit the use of other drug classes.

Upon completion of this program, you will be able to confidently identify patient groups likely to benefit from DPP4is, and have the knowledge to appropriately prescribe DPP4is.

This program was developed by MDBriefcase, and funding provided by Boehringer Ingelheim.

Course Details

Expiry Date: 2022-12-31

Professions: Physician

Faculty

Anita Sharma, General Practitioner, Queensland (QLD)

Tom Dover, Endocrinologist, Queensland (QLD)

Accreditation

This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.

Activity no. 300955

Members are able to claim CPD activity points for 2 points through ‘Quick log’ on their RACGP CPD Dashboard.

This course is endorsed and accredited by the ADEA for 1 CPD point.

Learning Objective(s)

Upon completion of this continuing education program participants will be better able to:

  • Review the use of DPP4is for patients with T2D in line with current guidelines
  • Identify patients for whom DPP4is are indicated and a good option from a clinical, practical and treatment goal perspective.
  • Determine when a DPP4i is an appropriate option as dual therapy or subsequent medication to reach individualised diabetes treatment goals.
  • Overcome clinician-mediated and patient-mediated clinical inertia to initiate timely escalation of diabetes treatment, with the aim of reaching glycaemic targets, improving medication adherence and considering patients’ preferences.
  • Confidently discuss with patients a DPP4i option, including counselling on the advantages and disadvantages of changing their medication in order to achieve a better clinical outcome.
This course is expired! Browse All Courses